日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
25/09/2024 | 施毅 | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
25/09/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
05/09/2024 | 田文志 | 1201(L) | -2,655,855(L) | 115,884,090(L) | 33.20 | |
05/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical LP | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
04/09/2024 | 施毅 | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | LAV ImmOn Hong Kong Limited | 1213(L) | 12,542,805(L) | 12,542,805(L) | 3.59 | |
04/09/2024 | LAV Biosciences Fund V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | LAV Corporate V GP, Ltd. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | LAV GP V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | Jiaxing Changxian Enterprise Management L.P. (Limited Partnership) (嘉興昶咸企業管理合夥企業(有限合夥)) | 1711(L) | -7,758,630(L) | 0(L) | 0.00 | |
04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
04/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | Halo Biomedical LP | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | 上海張科領弋升帆創業投資中心(有限合夥) | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
04/09/2024 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
04/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | 田文志 | 1711(L) | +50,269,972(L) | 118,539,945(L) | 33.96 | |
04/09/2024 | Jiaxing Changyu Enterprise Management L.P. (Limited Partnership) (嘉興昶宇企業管理合夥企業(有限合夥)) | 1711(L) | -7,419,847(L) | 0(L) | 0.00 | |
04/09/2024 | Ho Yao | 1701(L) | +4,002,918(L) | 16,011,675(L) | 4.59 | |
04/09/2024 | 田文志 | 1711(L) | -50,269,972(L) | 0(L) | 0.00 | |
04/09/2024 | LAV Asset Management (Hong Kong) Limited | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | 于曉勇 | 1113(L) | +25,750,000(L) | 31,304,305(L) | 8.97 | |
04/09/2024 | 于曉勇 | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
04/09/2024 | 上海張科領弋升帆創業投資中心(有限合夥) | 1113(L) | +25,750,000(L) | 25,750,000(L) | 7.38 | |
04/09/2024 | LAV ImmuneOnco Hong Kong Limited | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
03/09/2024 | Greater Bay Area Homeland Development Fund (GP) Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | Greater Bay Area Homeland Investments Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | 陈飞 | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
05/09/2023 | 施毅 | 1701(L) | +27,721,575(L) | 27,721,575(L) | 12.18 | |
05/09/2023 | 程义全 | 1701(L) | 16,560,270(L) | 7.28 | ||
05/09/2023 | 余治華 | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
05/09/2023 | 于曉勇 | 1701(L) | +5,554,305(L) | 5,554,305(L) | 2.44 | |
05/09/2023 | 陈飞 | 1701(L) | +7,967,925(L) | 7,967,925(L) | 5.47 | |
05/09/2023 | 北京龍磐健康醫療投資中心(有限合夥) | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
05/09/2023 | 于曉勇 | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
1 2 |
備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
(S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
(P) - 可供借出的股份 | |
即時報價更新時間為 30/09/2024 17:11 | |
港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權
權證
ETF
A股
外匯黃金
加密貨幣
基金
MPF